Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,389 public trials 159 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia

NCT01868893

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • University of California San Diego La Jolla, California, United States
  • Bay Area Cancer Research Group, LLC Pleasant Hill, California, United States
View all 19 locations
View Trial Details
Completed

A Study Comparing Obinutuzumab (RO5072759; GA101) 1000 Milligram (mg) Versus 2000 mg in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GAGE)

NCT01414205

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Univ of Alabama at Birmingham; UAB Comprehensive Cancer Ctr Birmingham, Alabama, United States
  • Arizona Oncology Tucson, Arizona, United States
  • Arizona Clinical Research Ctr Tucson, Arizona, United States
  • University of California; Moores Cancer Center La Jolla, California, United States
View all 31 locations
View Trial Details
Completed

Study of Intravenously Administered SNS-032 in Patients With Advanced B-lymphoid Malignancies

NCT00446342

Conditions
B-Lymphoid Malignancies, Blood Protein Disorders, Cardiovascular Diseases, +29 more
Locations
  • City of Hope Duarte, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Winship Cancer Institute at Emory University Atlanta, Georgia, United States
  • Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
View Trial Details
Completed

Tandem Auto-Allo Transplant for Lymphoma

NCT01181271

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse, Large B-Cell, Lymphoma, +27 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

NCT00755040

Conditions
Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +62 more
Locations
  • Stanford University Palo Alto, California, United States
  • Norwestern Memorial Hospital Chicago, Illinois, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • M. D. Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions